Literature DB >> 20064468

SH3 domains from a subset of BAR proteins define a Ubl-binding domain and implicate parkin in synaptic ubiquitination.

Jean-François Trempe1, Carol X-Q Chen, Karl Grenier, Edna Matta Camacho, Guennadi Kozlov, Peter S McPherson, Kalle Gehring, Edward A Fon.   

Abstract

Mutations in the parkin gene are responsible for a common inherited form of Parkinson's disease (PD). Parkin is a RING-type E3 ubiquitin ligase with an N-terminal ubiquitin-like domain (Ubl). We report here that the parkin Ubl binds SH3 domains from endocytic BAR proteins such as endophilin-A with an affinity comparable to proline-rich domains (PRDs) from well-established SH3 partners. The NMR structure of the Ubl-SH3 complex identifies the PaRK extension, a unique C-terminal motif in the parkin Ubl required for SH3 binding and for parkin-mediated ubiquitination of endophilin-A in vitro. In nerve terminals, conditions that promote phosphorylation enhance the interaction between parkin and endophilin-A and increase the levels of ubiquitinated proteins within PRD-associated synaptic protein complexes in wild-type but not parkin knockout brain. The findings identify a pathway for the recruitment of synaptic substrates to parkin with the potential to explain the defects in synaptic transmission observed in recessive forms of PD. 2009 Elsevier Inc.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 20064468     DOI: 10.1016/j.molcel.2009.11.021

Source DB:  PubMed          Journal:  Mol Cell        ISSN: 1097-2765            Impact factor:   17.970


  67 in total

Review 1.  Regulation of Parkin E3 ubiquitin ligase activity.

Authors:  Helen Walden; R Julio Martinez-Torres
Journal:  Cell Mol Life Sci       Date:  2012-04-19       Impact factor: 9.261

2.  Solution structure of the E3 ligase HOIL-1 Ubl domain.

Authors:  Steven A Beasley; Susan S Safadi; Kathryn R Barber; Gary S Shaw
Journal:  Protein Sci       Date:  2012-05-24       Impact factor: 6.725

3.  Structural basis of membrane bending by the N-BAR protein endophilin.

Authors:  Carsten Mim; Haosheng Cui; Joseph A Gawronski-Salerno; Adam Frost; Edward Lyman; Gregory A Voth; Vinzenz M Unger
Journal:  Cell       Date:  2012-03-30       Impact factor: 41.582

4.  The Sac1 domain of SYNJ1 identified mutated in a family with early-onset progressive Parkinsonism with generalized seizures.

Authors:  Catharine E Krebs; Siamak Karkheiran; James C Powell; Mian Cao; Vladimir Makarov; Hossein Darvish; Gilbert Di Paolo; Ruth H Walker; Gholam Ali Shahidi; Joseph D Buxbaum; Pietro De Camilli; Zhenyu Yue; Coro Paisán-Ruiz
Journal:  Hum Mutat       Date:  2013-07-19       Impact factor: 4.878

Review 5.  New approaches for studying synaptic development, function, and plasticity using Drosophila as a model system.

Authors:  C Andrew Frank; Xinnan Wang; Catherine A Collins; Avital A Rodal; Quan Yuan; Patrik Verstreken; Dion K Dickman
Journal:  J Neurosci       Date:  2013-11-06       Impact factor: 6.167

6.  Policing Parkin with a UblD.

Authors:  Fen Liu; Kylie J Walters
Journal:  EMBO J       Date:  2011-07-20       Impact factor: 11.598

Review 7.  How mitochondrial dynamism orchestrates mitophagy.

Authors:  Orian S Shirihai; Moshi Song; Gerald W Dorn
Journal:  Circ Res       Date:  2015-05-22       Impact factor: 17.367

Review 8.  Autophagy in Parkinson's Disease.

Authors:  Xu Hou; Jens O Watzlawik; Fabienne C Fiesel; Wolfdieter Springer
Journal:  J Mol Biol       Date:  2020-02-13       Impact factor: 5.469

9.  PARK20 caused by SYNJ1 homozygous Arg258Gln mutation in a new Italian family.

Authors:  Simone Olgiati; Anna De Rosa; Marialuisa Quadri; Chiara Criscuolo; Guido J Breedveld; Marina Picillo; Sabina Pappatà; Mario Quarantelli; Paolo Barone; Giuseppe De Michele; Vincenzo Bonifati
Journal:  Neurogenetics       Date:  2014-05-10       Impact factor: 2.660

Review 10.  Endosomal sorting pathways in the pathogenesis of Parkinson's disease.

Authors:  Lindsey A Cunningham; Darren J Moore
Journal:  Prog Brain Res       Date:  2020-03-16       Impact factor: 2.453

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.